NEUP · CIK 0001191070 · operating
Neuphoria Therapeutics Inc. (NEUP) is a pharmaceutical preparations company incorporated in Australia, listed on the Nasdaq. With a market capitalization of $23 million, Neuphoria Therapeutics Inc. is a micro-cap company. The stock currently trades at $4.31, up 3.86% today, with a 52-week range of $3.65–$21.40.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.23 | $-0.23 | -2200.0% | |
| 2024 | $-0.01 | $-0.01 | — |